The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Dec 2017 09:00

RNS Number : 0526A
Royal Bank of Scotland Group PLC
21 December 2017
 

21 December 2017

The Royal Bank of Scotland Group plc 

LEI: 2138005O9XJIJN4JPN90

Directorate Changes

The Royal Bank of Scotland Group plc ("RBS") announces today that with effect from 1 January 2018:-

· Sir Sandy Crombie will step down as a non-executive director of RBS, and as Senior Independent Director and Chairman of the Group Performance & Remuneration Committee;

· Robert Gillespie will assume the role of Chairman of the Group Performance & Remuneration Committee;

· Mark Seligman will assume the role of Senior Independent Director and will be appointed as a member of the Group Performance & Remuneration Committee; and

· Dr Lena Wilson, CBE will be appointed as a non-executive director of RBS.

Howard Davies, Chairman of RBS, said:

"Sandy Crombie has made an outstanding contribution to the Board of RBS and we have benefitted greatly from his wisdom and experience. The Board and I will miss Sandy's presence as a much valued colleague and friend, and he leaves RBS with our very best wishes for the future.

I am delighted that Robert Gillespie will be building on Sandy's excellent work as Chairman of the Group Performance & Remuneration Committee, and that Mark Seligman is assuming the pivotal role of Senior Independent Director. Robert and Mark are both ideally suited to these positions, and I know they will have much to contribute. Mark will also join the Group Performance & Remuneration Committee.

Finally, we are very pleased to welcome Dr Lena Wilson as a non-executive director. With her strong public sector and commercial background, I am confident that Lena's appointment will further strengthen the RBS Board's composition and we look forward to welcoming her to the Board."

Lena Wilson has been a non-executive director and member of the audit committee of Intertek Group plc since 2012.

There are no other matters requiring disclosure under Listing Rule 9.6.13.

For further information contact:

RBS Media Centre +44 131 523 4205

Notes to Editors

Biographical Details

Dr Lena Wilson, CBE

Lena Wilson was Chief Executive of Scottish Enterprise from November 2009 until October 2017, having previously held the roles of Chief Operating Officer, Chief Executive Officer, Scottish Development International (Scotland's international trade and investment arm) and Senior Director, Customer Relations. Prior to that, Lena was Senior Investment Advisor to The World Bank in Washington DC, advising developing countries on foreign direct investment and private sector development.  Lena has also served as a member of Scotland's Financial Services Advisory Board and as Chair of Scotland's Energy Jobs Taskforce.

Lena has been a non-executive director and member of the audit committee of Intertek Group plc since 2012 and was appointed as a non-executive director of Scottish Power Renewables Limited in November 2017. She is also an ambassador for The Prince & Princess of Wales Hospice (Glasgow) and the Edinburgh Military Tattoo, and served on the Board of the Prince's Scottish Youth Business Trust for 10 years. In June 2015, Dr Wilson received a CBE for her services to economic development in Scotland.

Robert Gillespie

Robert Gillespie joined the RBS Board in December 2013 and is a member of the Group Nominations & Governance Committee, Group Performance and Remuneration Committee, Sustainable Banking Committee and GRG Board Oversight Committee. He is also an independent board director at Ashurst LLP and Chairman of Council at the University of Durham. Robert began his career with Price Waterhouse where he qualified as a chartered accountant. He then moved into banking, joining SG Warburg and specialising in corporate finance, and was appointed as Co-Head and Managing Director of its US investment banking business in 1989. Following the acquisition in 1995 of Warburg by Swiss Bank Corporation (which subsequently merged with UBS), he then held various management roles before being appointed Vice Chairman of UBS Bank. Robert was also seconded to the UK Panel on Takeovers and Mergers as Director General, from 2010 to 2013.

Mark Seligman

Mark Seligman joined the RBS Board in April 2017 and is a member of the Group Nominations & Governance Committee. He has substantial FTSE 100 Board experience and is currently Senior Independent Director of Kingfisher plc, and a non-executive director of Smiths Group plc. Mark previously served as a non-executive Director of BG Group plc and as Deputy Chairman of G4S plc. During his executive career, Mark held various senior roles at Credit Suisse / BZW (including Deputy Chairman, CSFB Europe and Chairman, UK Investment Banking, CSFB); and previously SG Warburg (ultimately as Managing Director, Head of Advisory).  

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGIBDDSUDBGRB
Date   Source Headline
5th Nov 20184:21 pmRNSPublication of Suppl.Prospcts
2nd Nov 20185:25 pmRNSPublication of 2018 EBA EU-wide stress test result
2nd Nov 20182:10 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSUK intra-Group capital & liquidity arrangements
31st Oct 20182:38 pmRNSTotal Voting Rights
31st Oct 20187:00 amRNSDividend Declaration
30th Oct 20184:05 pmRNSDirector/PDMR Shareholding
29th Oct 20183:46 pmRNSDirector/PDMR Shareholding
26th Oct 20187:00 amRNSInterim Management Statement
9th Oct 20182:07 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:43 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20183:00 pmRNSDirector/PDMR Shareholding
28th Sep 201812:32 pmRNSTotal Voting Rights
25th Sep 201811:23 amRNSPricing of USD Fixed Rate to Floating Rate Notes
25th Sep 20187:00 amRNSBofAML Annual Financial CEO Conference
24th Sep 20189:00 amRNSRBS Investor SeminarUK Personal & Business Banking
17th Sep 201812:05 pmRNSPublication of Final Terms
13th Sep 201812:25 pmRNSForm 8.3 - CareTech Holdings
13th Sep 20188:00 amRNSBarclays Global Financial Services Conference
3rd Sep 20186:00 pmRNSPublication of Final Terms
31st Aug 20184:42 pmRNSTotal Voting Rights
31st Aug 20184:15 pmRNSNatWest Markets N.V. Interim Results 2018
22nd Aug 20185:01 pmRNSDividend Declaration
21st Aug 20183:32 pmRNSPublication of Suppl.Prospcts
17th Aug 20187:00 amRNSDirectorate Change
15th Aug 20187:00 amRNSDeclaration of Interim Dividend
13th Aug 20189:00 amRNSUpdate on ring-fencing plans
3rd Aug 20182:25 pmRNSForm 8.3 - [CareTech Holdings]
3rd Aug 20187:00 amRNSHalf-year Report
31st Jul 20182:44 pmRNSUpdate on ring-fencing plans
31st Jul 201812:04 pmRNSTotal Voting Rights
26th Jul 201812:17 pmRNSForm 8.3 - CareTech Holdings PLC
23rd Jul 20182:10 pmRNSForm 8.3 - CareTech Holdings plc
17th Jul 201811:46 amRNSRBS welcomes credit ratings action by Moody's
16th Jul 20186:18 pmRNSAllotment and Issue of New Ordinary Shares
16th Jul 20184:18 pmRNSForm 8.3 - CareTech Holdings plc
2nd Jul 20182:47 pmRNSCapital reduction - notice of completion
29th Jun 201812:51 pmRNSTotal Voting Rights
27th Jun 20184:36 pmRNSHolding(s) in Company
25th Jun 201811:52 amRNSPublication of Final Terms
22nd Jun 20185:28 pmRNSPublication of Final Terms
21st Jun 201811:52 amRNSPricing of USD Dual-Tranche Notes
8th Jun 20189:23 amRNSTR-1 Notification of major shareholdings
7th Jun 20189:00 amRNSGoldman Sachs European Financials Conference
5th Jun 20187:00 amRNSDisposal of approximately 7.7% of RBS Group plc.
4th Jun 20184:36 pmRNSIntention to dispose of c7.7% of RBS Group plc.
31st May 20185:32 pmRNSTotal Voting Rights
31st May 20184:30 pmRNSRBS notes credit rating actions by Standard&Poor's
31st May 201812:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.